SALVADOR PRIETO: Open Payments
NPI 1306110085 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,053 in 27 payments from 10 companies in 2025. Trend: 2023 $1,153 · 2024 $1,186 · 2025 $1,053
Food & beverage: $1,053
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 8 | $420 |
| Gilead Sciences, Inc. | 3 | $274 |
| Insmed, Inc. | 4 | $110 |
| Aimmune Therapeutics, Inc. | 4 | $73 |
| Astellas Pharma US Inc | 3 | $67 |
| Grifols USA, LLC | 1 | $28 |
| Octapharma USA, Inc. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Shionogi Inc | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
Products named: Arikayce, DOVATO, VOWST, Cresemba, APRETUDE, CABENUVA, Gamunex-C, OCTAGAM IMMUNE GLOBULIN (HUMAN).
Industry payments across TX — which companies pay providers there.
